Boundless Bio, Inc. (BOLD) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -14.97M | -10.11M | -10.2M | -11.83M | -14.53M | -15.56M | -13.27M | -16.24M | -15.78M | -11.69M | -12.19M | -10.89M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -3.04% | 35.06% | 23.15% | 27.14% | 7.9% | -33.18% | -8.84% | -49.09% | - | -14.76% | - | - |
| Net Income | -13.55M | -12.88M | -13.88M | -15.68M | -15.76M | -16.45M | -16.51M | -16.98M | -15.43M | -12.14M | -13.17M | -12.4M |
| Depreciation & Amortization | 284K | 307K | 310K | 317K | 317K | 296K | 262K | 265K | 263K | 247K | 235K | 238K |
| Stock-Based Compensation | 0 | 1.33M | 1.3M | 1.69M | 1.8M | 2.01M | 2.04M | 2.13M | 1.33M | 911K | 883K | 927K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.28M | 0 |
| Other Non-Cash Items | 1.87M | 308K | 224K | 125K | 41K | -293K | -682K | -1.07M | -354K | -520K | 602K | -158K |
| Working Capital Changes | -3.57M | 831K | 1.85M | 1.71M | -927K | -1.13M | 1.62M | -587K | -1.58M | -180K | 544K | 501K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -3.07M | 977K | 1.54M | 1.2M | -2.08M | -2.05M | 1.78M | 1.25M | -210K | 549K | 0 | 0 |
| Cash from Investing | 14.59M | 12.97M | 10.48M | 11.29M | 3.06M | 1.82M | 22.13M | -68.19M | 18.14M | 15.81M | -7.72M | -68.52M |
| Capital Expenditures | -8K | -424K | -15K | -48K | -59K | -466K | -483K | -1.5M | -83K | -268K | -151K | -128K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 24K | 0 | 117K | 0 | 113K | -13K | 90.65M | -924K | -1.38M | -447K | 99.7M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 24K | 0 | 117K | 0 | 113K | -13K | 90.65M | -924K | -1.38M | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 117K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -447K | 99.7M |
| Net Change in Cash | -385K | 2.89M | 283K | -420K | -11.47M | -13.63M | 8.85M | 6.22M | 1.44M | 2.74M | -20.35M | 20.29M |
| Free Cash Flow | -14.98M | -10.53M | -10.21M | -11.88M | -14.59M | -16.03M | -13.75M | -17.74M | -15.86M | -11.95M | -12.34M | -11.02M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -2.68% | 34.3% | 25.74% | 33.05% | 8.01% | -34.09% | -11.42% | -61.01% | - | -16.94% | - | - |
| FCF per Share | -0.67 | -0.47 | -0.46 | -0.53 | -0.65 | -0.94 | -0.62 | -0.81 | -0.71 | -0.54 | -0.55 | -0.50 |
| FCF Conversion (FCF/Net Income) | 1.10x | 0.78x | 0.73x | 0.75x | 0.92x | 0.95x | 0.80x | 0.96x | 1.02x | 0.96x | 0.93x | 0.88x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |